HopeStage
Back to all studies
RecruitingNCT06349083

Psilocybin-assisted therapy or placebo for alcohol use: brain and behavior study

About this titleRead the official source — NCT06349083
Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

Participants are randomly assigned to one oral session with psilocybin or matching placebo (an inactive comparison treatment). Both groups also receive four supportive therapy sessions from clinicians.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: September 1, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
200
Sponsor
NYU Langone Health
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Behavioural, Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06349083
Official title
Show the full official title

Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder

Recruitment & locations

Currently recruiting

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is NYU Langone Health.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies